1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
20.86%
Revenue growth of 20.86% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
-21.47%
Negative gross profit growth while Healthcare median is 0.00%. Seth Klarman would suspect poor product pricing or inefficient production.
-27.53%
Negative EBIT growth while Healthcare median is 0.00%. Seth Klarman would check if external or internal factors caused the decline.
-27.53%
Negative operating income growth while Healthcare median is 0.00%. Seth Klarman would check if structural or cyclical issues are at play.
686.38%
Net income growth of 686.38% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
671.43%
EPS growth of 671.43% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
669.28%
Diluted EPS growth of 669.28% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-12852.71%
Negative OCF growth while Healthcare median is -11.35%. Seth Klarman would ask if accounting or macro issues hamper the firm specifically.
5.64%
Positive FCF growth while Healthcare median is negative. Peter Lynch might view this as a notable advantage over peers.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1150.19%
Negative 10Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would suspect the firm is failing to keep pace with industry peers.
-1150.19%
Negative 5Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman might see a firm-specific issue if peers still expand cash flow.
-11.55%
Negative 3Y OCF/share CAGR while Healthcare median is 0.00%. Seth Klarman would check whether it’s cyclical or a firm-specific problem.
2791.98%
Net income/share CAGR exceeding 1.5x Healthcare median of 9.51% over a decade. Joel Greenblatt might see a standout compounder of earnings.
2791.98%
5Y net income/share CAGR > 1.5x Healthcare median of 1.60%. Joel Greenblatt might see superior mid-term capital allocation or product strength.
4465.63%
3Y net income/share CAGR > 1.5x Healthcare median of 0.20%. Joel Greenblatt might see a recent surge from market share gains or cost synergy.
1891.94%
Equity/share CAGR of 1891.94% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
1891.94%
5Y equity/share CAGR > 1.5x Healthcare median of 20.07%. Joel Greenblatt sees a possible ROE advantage or fewer share issuances boosting book value.
4563.18%
3Y equity/share CAGR > 1.5x Healthcare median of 1.53%. Joel Greenblatt sees strong short-term returns on equity fueling net worth growth.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
98.77%
AR growth of 98.77% while Healthcare median is zero. Walter Schloss checks if the difference points to new credit strategy or stronger sales push.
63.89%
Inventory growth of 63.89% while Healthcare median is zero. Walter Schloss checks if we’re preparing for a sales push or risking overstock.
11.84%
We expand assets while Healthcare is negative. Peter Lynch sees a possible advantage if expansions align with profitable markets or a recovering cycle.
13.20%
BV/share growth of 13.20% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
5.20%
Debt growth of 5.20% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
96.49%
R&D growth of 96.49% while Healthcare median is zero. Walter Schloss wonders if a slight increase yields a meaningful competitive edge.
97.59%
SG&A growth of 97.59% while Healthcare median is zero. Walter Schloss sees a modest overhead increase needing revenue justification.